Cyclic AMP-Mediated Inhibition of Cholesterol Catabolism in by the Novel Drug Candidate GSK2556286.

Antimicrobial agents and chemotherapy, Volume: 67, Issue: 1
January 24, 2023
Kirstin L Brown KL, Kaley M Wilburn KM, Christine R Montague CR, Jason C Grigg JC, Olalla Sanz O, Esther Pérez-Herrán E, David Barros D, Lluís Ballell L, Brian C VanderVen BC, Lindsay D Eltis LD

Despite the deployment of combination tuberculosis (TB) chemotherapy, efforts to identify shorter, nonrelapsing treatments have resulted in limited success. Recent evidence indicates that GSK2556286 (GSK286), which acts via Rv1625c, a membrane-bound adenylyl cyclase in Mycobacterium tuberculosis, shortens treatment in rodents relative to standard of care drugs. Moreover, GSK286 can replace linezolid in the three-drug, Nix-TB regimen. Given its therapeutic potential, we sought to better understand the mechanism of action of GSK286. The compound blocked growth of in cholesterol media and increased intracellular cAMP levels ~50-fold. GSK286 did not inhibit growth of an transposon mutant in cholesterol media and did not induce cyclic AMP (cAMP) production in this mutant, suggesting that the compound acts on this adenylyl cyclase. GSK286 also induced cAMP production in Rhodococcus jostii RHA1, a cholesterol-catabolizing actinobacterium, when Rv1625c was heterologously expressed. However, these elevated levels of cAMP did not inhibit growth of RHA1 in cholesterol medium. Mutations in conferred cross-resistance to GSK286 and the known Rv1625c agonist, mCLB073. Metabolic profiling of cells revealed that elevated cAMP levels, induced using either an agonist or a genetic tool, did not significantly affect pools of steroid metabolites in cholesterol-incubated cells. Finally, the inhibitory effect of agonists was not dependent on the -acetyltransferase MtPat. Together, these data establish that GSK286 is an Rv1625c agonist and sheds light on how cAMP signaling can be manipulated as a novel antibiotic strategy to shorten TB treatments. Nevertheless, the detailed mechanism of action of these compounds remains to be elucidated.

Courtesy of the U.S. National Library of Medicine